Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Patent
1994-04-22
1999-02-23
Huff, Sheela
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
536 231, 530350, C07H 2102, C07H 2104
Patent
active
058745602
ABSTRACT:
The present invention provides a nucleic acid sequence encoding a melanoma antigen recognized by T lymphocytes, designated MART-1. This invention further relates to bioassays using the nucleic acid sequence, protein or antibodies of this invention to diagnose, assess or prognoses a mammal afflicted with melanoma or metastata melanoma. This invention also provides immunogenic peptides derived from the MART-1 melanoma antigen and a second melanoma antigen designated gp100. The proteins and peptides provided can serve as an immunogen or vaccine to prevent or treat melanoma.
REFERENCES:
patent: 5262177 (1993-11-01), Brown et al.
patent: 5342774 (1994-08-01), Boon et al.
patent: 5679511 (1997-10-01), Kwon
Lewin, Science vol. 237 p. 1570, 1987.
Reeck et al, Cell vol. 50 p. 667, Aug. 1987.
Storkus, W.J. et al. (1993) "Identification of human melanoma peptides recognized by Class I restricted tumor infiltrating T lymphocytes" J. Immunol. 151(7):3719-3727.
Kawakami, Yutaka et al. (1994) "Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor" Proc. Natl. Acad. Sci. U.S.A. 91(9):3515-3519.
Falk, K., et al.: "Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules." Nature 1991, 351:290-296.
Kubo, R., et al.: "Definition of specific peptide motifs for four major HLA-A Alleles." Journal of Immunology 1994, 152:3913-3924.
Parker, K., et al.: "Sequence motifs important for peptide binding to the human MHC class 1 molecule. HLA-A2." 1992, J. Immunol:3580-3587.
Ruppert, J., et al.: "Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules." Cell 1993, 74:929-937.
Kawakami, Y., et al.: "Identification of human melanoma antigen recognized by trans-infiltrating lymphocytes associated with in vivo tumor rejection." Pro. Natl. Acad. Sci. USA 1994, 91:6458-6462.
Adema, G.J. et al., "Molecular characterization of the melanocyte lineage-specific antigen gp100." Journal of Biological Chemistry 1994, 269:20126-20133.
EMBL Database Accession No. M32295: 26-11-90 Vogel A.: Human KD melanocyte specific secreted glycoprotein MRNA 3'end'.
Sette, et al., "Peptide Binding to the Most Frequent HLA-A Class I Alleles Measured by Quantitative Molecular Binding Assays" Molecular Immunology 31:813-822 (1994).
Wolfel, et al., "Analysis of Antigens Recognized in Human Melanoma Cells by A2-Restricted Cytolytic T-Lymphocytes (CTL)" Int. J. Cancer 1993 55:237-244.
Wolfel, et al., "Isolation of Naturally Processed Peptides Recognized by Cytolytic Lymphocytes (CTL) on Human Melanoma Cells In Association with HLA-A2.1" Int. J. Cancer 1994 413-418.
Slingluff, C.L., et al., "Recognition of Human Melanoma Cells by HLA-A2.1 Restricted Cytotoxic 7-Lymphocytes as Mediated by Six Strand Peptide Epitopes" Journal of Immunology 1993:150:2955-2963.
Genbank Accession No. M77348 "Human PMEL 17 mRNA" Jan. 8, 1995.
Genbank Accession No. U06654 "Human Differentiation Antigen Melan-A Protein in RNA" Jul. 30, 1994.
Genbank Accession No. S73003 "GP100 Melanocyte Lineage Specific Antigen/PMELL7 Honolog" Jan. 25, 1995.
Genbank Accession No. U01874 "Human ME20 in RNA" May 27, 1994.
Coulie, P.G. et al. (1993) "Genes coding for tumor antigens recognized by human cytolytic T-lymphocytes" J. Immunotherap. 14:104-109.
Coulie P.G. et al. "A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas", J. Exp Med (1994) 180:35-42.
Maresh, C.A. et al.: Cloning and expression of the gene for the melanoma associated ME20 antigen. DNA and Cell Biology, 1994; 13:87-95.
Cox, A.L., et al. "Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines" Science 1994; 264:716-719.
Brichard, V., et al.: "The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas". J. Exp. Med. 1993; 178:489-495.
Gaugler, B., et al. "Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes". J. Exp. Med. 1994; 179:921-930.
Traversari, C., et al.: "A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E". J. Exp. Med. 1992; 176:1453-1457.
Cellis, E., et al.: "Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptides epitopes". Proc. Natl. Acad. Sci. U.S.A. 1994; 91:2105-2109.
Boon, T.: "Toward a genetic analysis of tumor rejection antigens". Adv. Cancer Res. 1992; 58:177-210.
Kawakami, Y., et al.; T-cell recognition of human melonoma antigens. J. Immunother. 1993; 14:88-93.
Bakker, A.B.H., et al.: Melanocyte lineage-specific antigen gp100 is recognized by melanocyte-derived tumor infiltrating lymphocytes. J. Exp. Med. 1994; 179:1005-1009.
Wolfel, T., et al.: Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T. lymphocytes. Eur. J. Immunol. 1994; 24:759-764.
Adema, G.J., et al.: Melanocyte lineage-specific antigens recognized by monoclonal antibodies NK1-beteb, HMB-50, and HMB-45 are encoded by a single cDNA. Am. J. Pathol. 1993; 143:1579-1585.
Kwon, B.S., et al.: A melanocyte-specific gene, Pmel 17, maps near the silver coat color locus on mouse chromosome 10 and is in a syntenic region on human chromosome 12. Proc. Natl. Acad. Sci. USA 1991; 88:9228-9232.
Rosenberg, S.A., et al.: Use of tumor infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. Preliminary report. N. Engl. J. Med. 1988; 319:1676-1680.
Kawakami, Y., et al.,: Shared human melanoma antigens. Recognition by tumor infiltrating lymphocytes in HLA-A2.1 transfected melanomas. J Immunol 1992; 148:638-643.
Van der Bruggen, et al.: A gene encoding an antigen recognized by cytolytic T. lymphocytes on a human melanoma. Science 1991; 254:1643-1647.
Webster's 11 New Riverside Dictionary p. 365, 1984.
Kawakami Yutaka
Rosenberg Steven A.
Huff Sheela
The United States of America as represented by the Department of
LandOfFree
Melanoma antigens and their use in diagnostic and therapeutic me does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Melanoma antigens and their use in diagnostic and therapeutic me, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Melanoma antigens and their use in diagnostic and therapeutic me will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-308311